Owner Janssen Pharmaceutica N.V.

Inventors Apodaca, Richard; Seierstad, Mark; Xiao, Wei; Breitenbucher, J. Guy; Pattabiraman, Kanaka

Agent Shelston IP

Pub. Number AU-B-2005322920

PCT Pub. Number WO2006/074025

Priority 60/640,869 30.12.04 US

Filing date 29 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 21 June 2012

C07D 295/20 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61P 25/04 Drugs for disorders of the nervous system

A61P 25/22 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

C07C 275/28 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/42 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group